Setmelanotide, an MC4R Agonist, for Obesity in Individuals with Smith-Magenis Syndrome
Published: 26 April 2024| Version 1 | DOI: 10.17632/hxv6jxmp2j.1
Contributor:
Jack YanovskiDescription
Underlying data presented in manuscript titled, "Setmelanotide, an MC4R Agonist, for Obesity in Individuals with Smith-Magenis Syndrome"
Files
Steps to reproduce
See manuscript for analysis details.
Institutions
National Institute of Child Health and Human Development
Categories
Pharmacotherapy, Cholesterol, Body Weight, Body Fat Mass
Funding
Rhythm Pharmaceuticals